Searched for
MAYANK SINGHAL
2-hour hospitalisation: What health insurance policies really cover and what they excludeNew health plans cover treatments requiring two hours of hospitalisation, but exclusions remain critical.
Pick your own health cover: How custom plans work and their hidden downsidesA health plan consists of a base plan and riders or add-ons. Earlier, the base plan comprised fixed features that could not be changed, and...
Micro-drama OTT platform Flick TV raises $2.3 million in round led by Stellaris Venture PartnersGemba Capital and Titan Capital participated in this round. According to founder Kushal Singhal, the funds will be used to scale content pr...
Buy PI Industries, target price Rs 3750: Jayesh BhanushaliPI Industries, incorporated in the year 1946, is a Large Cap company (having a market cap of Rs 54221.78 Crore) operating in Pesticides/Agr...
Buy PI Industries, target price Rs 4200: Sharekhan by BNP ParibasThe brokerage expects PI’s revenue/EBITDA/PAT to post a strong CAGR of 20%/19%/19% over FY2023-FY2025E, led by robust CSM order book of $1....
Buy PI Industries, target price Rs 4200: Sharekhan by BNP ParibasPI Industries, incorporated in the year 1946, is a Large Cap company (having a market cap of Rs 52147.03 Crore) operating in Pesticides/Agr...
Buy PI Industries, target price Rs 3550: Jayesh BhanushaliPI Industries, incorporated in the year 1946, is a Large Cap company (having a market cap of Rs 52184.21 Crore) operating in Pesticides/Agr...
Buy PI Industries, target price Rs 3575: JM FinancialPI Industries, incorporated in the year 1946, is a Large Cap company (having a market cap of Rs 44772.02 Crore) operating in Pesticides/Agr...
Buy PI Industries Ltd., target price Rs 4200 : Sharekhan by BNP ParibasPI Industries, incorporated in the year 1946, is a Large Cap company (having a market cap of Rs 53910.76 Crore) operating in Pesticides/Agr...
Buy PI Industries, target price Rs 3790: JM FinancialFor the quarter ended June 30, 2022, the company has reported a consolidated total income of Rs 1567.30 crore, up 10.75 per cent from last ...
Promoter offloads 10 lakh shares of PI Industries for Rs 315 croreThe entities that purchased the stake are -- Mirae Asset MF, Sundaram MF, Tara Emerging Asia Liquid Fund, Morgan Stanley Asia Singapore Pte...
Buy PI Industries, price target Rs 1,510: Jayesh BhanushaliThe analyst suggested a stoploss at Rs 1440.
Expect export demand to revive in H2FY18; don't see currency to impact us drastically: Mayank Singhal, PI IndustriesMayank Singhal of PI Industries says that because of the schedules of delivery, we expect the demand will be back.
Global agrochemical environment looks challenging in near term: Mayank Singhal of PI IndustriesI would broadly say the Agri season-- the first part of the season has not been so favourable although the acreages in crops were up but th...
Expect to be back on track by late 2017-18: Mayank Singhal, PI Industries“I do expect this rabi season to be much better than the ones in the last couple of years. And that definitely is going to be a benefit to ...
Agri domestic business should be better in next couple of quarters: Mayank Singhal, MD & CEO, PI IndustriesI assume if the cropping patterns in the way they are picking up, this should all clear up and then the space for growth for all companies ...
Expect 18-20% growth for PI in next one year: Mayank Singhal, MD & CEO"As a business as we are achieving scale and height. Growth numbers are definitely going to continue to shore up, but we believe in setting...
Agrochem industry expected to double in next five years: Mayank Singhal, PI IndustriesThe Indian agrochem industry is expected to be between $2 billion and $2.5 billion, and is expected to double in the next five years.
Expect to sustain margins going forward: Mayank Singhal, PI Industries'Going forward, we expect to see a continued growth of about 25% in the coming year,' says Singhal.
- Expect strong growth for agri input & CRAMS in FY12: Mayank Singhal, PI Industries
Going by non-compete business model, not competing with the generic companies, says Mayank Singhal, MD & CEO, PI Industries.